Novel Piperazine Based Compounds Target Alzheimer’s Disease Relevant Amyloid β42 and Tau Derived Peptide AcPHF6, and the Lead Molecule Increases Viability in the Flies Expressing Human Tau Protein
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.4c00220 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Christopher Armstrong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, tau Proteins, Alzheimer Disease, Peptide Fragments. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, United States.
- Department of Pharmacology, Wayne State University, Detroit, Michigan 48201, United States.
- Department of Neurology, Wayne State University, Detroit, Michigan 48201, United States.
ORCID-Profile: Aloke K Dutta
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Armstrong, C., Luo, D., Gretzinger, A., Pandey, D., Lipchik, A., Todi, S. V., & Dutta, A. K. (2024). Novel Piperazine Based Compounds Target Alzheimer’s Disease Relevant Amyloid β42 and Tau Derived Peptide AcPHF6, and the Lead Molecule Increases Viability in the Flies Expressing Human Tau Protein. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00220
Vancouver
Armstrong C, Luo D, Gretzinger A, Pandey D, Lipchik A, Todi SV, et al. Novel Piperazine Based Compounds Target Alzheimer’s Disease Relevant Amyloid β42 and Tau Derived Peptide AcPHF6, and the Lead Molecule Increases Viability in the Flies Expressing Human Tau Protein. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00220
BibTeX
@article{Armstrong2024,
author = {Armstrong, Christopher and Luo, Dan and Gretzinger, Anna and Pandey, Deepti and Lipchik, Andrew and Todi, Sokol V and Dutta, Aloke K},
title = {Novel Piperazine Based Compounds Target Alzheimer’s Disease Relevant Amyloid β42 and Tau Derived Peptide AcPHF6, and the Lead Molecule Increases Viability in the Flies Expressing Human Tau Protein},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.4c00220}
}
EUVIMED